Chlamydia trachomatis in subfertile couples undergoing an in vitro fertilization program: A prospective study
article
OA: closed
CC0
⤵ 3 in-corpus citations
AI-generated summary
This prospective study investigated the prevalence of *Chlamydia trachomatis* infections in subfertile couples participating in an in vitro fertilization program.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectivesThe objectives were to estimate the prevalence of Chlamydia trachomatis infection in subfertile couples and to study the relationship between markers of C. trachomatis infection and male infertility as well as pregnancy rates after in vitro fertilization (IVF).Study designAll consecutive couples consulting for infertility and IVF in Pellegrin Hospital were screened for C. trachomatis by direct (PCR test) and serological methods.ResultsTwo hundred and seventy-seven couples were included in the study (mean age in years: 35 for men, 32 for women; mean duration of infertility: 4 years). The most frequent indication for IVF was tubal factor in 33%, endometriosis in 6%, dysovarian function in 12%, male infertility in 36% and others in 13%. C. trachomatis PCR was positive in 1.2% of men, 95% confidence interval (CI95%): (0.2%; 3.3%) and in 2.7% of women, CI95%: (1.1%; 5.5%). When combining all chlamydial markers, 17.3% of men, CI95%: (12.7%; 22.8%) and 20.4% of women, CI95%: (15.6%; 25.9%) had at least one positive marker. The presence of positive markers was not associated with altered semen characteristics. Couples with positive markers had a pregnancy rate of 23.1% (12 out of 52) compared with 20.2% (24 out of 119) among those with negative markers.ConclusionIn this population, the presence of past or current C. trachomatis infection was associated with neither semen characteristics nor outcome of IVF in subfertile couples.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (3)
References (34)
- W175138886 via openalex
- W1543430251 via openalex
- W1587475887 via openalex
- W2001753833 via openalex
- W2018006613 via openalex
- W2035294803 via openalex
- W2035635602 via openalex
- W2048437055 via openalex
- W2057231661 via openalex
- W2061493411 via openalex
- W2065736305 via openalex
- W2076097357 via openalex
- W2087013603 via openalex
- W2098935890 via openalex
- W2102757069 via openalex
- W2107239395 via openalex
- W2109661320 via openalex
- W2109809405 via openalex
- W2113802387 via openalex
- W2115514659 via openalex
- W2117612131 via openalex
- W2117813650 via openalex
- W2120378397 via openalex
- W2127863842 via openalex
- W2132683680 via openalex
- W2136159543 via openalex
- W2140990562 via openalex
- W2166173416 via openalex
- W2170598238 via openalex
- W2297953774 via openalex
- W2311167413 via openalex
- W2342385460 via openalex
- W4233238014 via openalex
- W6607238088 via openalex
Cited by (3)
Source provenance
- europepmc
- last seen: 2026-08-21T06:14:13.963979+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:15:18.313808+00:00
License: CC0
· commercial use OK